These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 6405009)

  • 21. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
    Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
    Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow Cytometric Assays to Quantify fHbp Expression and Detect Serotype Specific Capsular Polysaccharides on Neisseria meningitidis.
    Loschko J; Garcia K; Cooper D; Pride M; Anderson A
    Methods Mol Biol; 2019; 1969():217-236. PubMed ID: 30877680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
    Jennings HJ; Roy R; Gamian A
    J Immunol; 1986 Sep; 137(5):1708-13. PubMed ID: 3091688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunity against Neisseria meningitidis in different population groups].
    Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
    Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immune response to the capsular polysaccharide of Neisseria meningitidis group B.
    Romero JD; Outschoorn IM
    Zentralbl Bakteriol; 1997 Feb; 285(3):331-40. PubMed ID: 9084108
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polysaccharides of the genus Bacillus cross-reactive with the capsular polysaccharides of Diplococcus pneumoniae type 3, Haemophilus influenzae type b, and Neisseria meningitidis group A.
    Myerowitz RL; Gordon RE; Robbins JB
    Infect Immun; 1973 Dec; 8(6):896-900. PubMed ID: 4150383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of the immune response to a modified group B meningococcal polysaccharide conjugate vaccine.
    Moore S; Farley EK; Fusco PC; Michon F
    Clin Vaccine Immunol; 2007 Jan; 14(1):106-9. PubMed ID: 17079431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis.
    Jennings HJ; Gamian A; Ashton FE
    J Exp Med; 1987 Apr; 165(4):1207-11. PubMed ID: 2435835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine].
    Golovina LI; Kuvakina VI; Alliluev AP; Basnak'ian IA; Sivko RI
    Klin Lab Diagn; 1995; (1):26-9. PubMed ID: 7757362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum factors and polymorphonuclear leukocytes in human host defence against Neisseria meningitidis. Studies of interactions with special reference to a chemiluminometric technique.
    Fredlund H
    Scand J Infect Dis Suppl; 1993; 87():1-72. PubMed ID: 8511525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to four Neisseria meningitidis serogroups.
    Martins TB; Jaskowski TD; Tebo A; Hill HR
    J Immunol Methods; 2009 Mar; 342(1-2):98-105. PubMed ID: 19159627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.
    Guirguis N; Schneerson R; Bax A; Egan W; Robbins JB; Shiloach J; Orskov I; Orskov F; el Kholy A
    J Exp Med; 1985 Dec; 162(6):1837-51. PubMed ID: 3934317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic specificity of bactericidal antibodies in antisera to Neisseria meningitidis.
    Kasper DL; Winkelhake JL; Brandt BL; Artenstein MS
    J Infect Dis; 1973 Apr; 127(4):378-87. PubMed ID: 4121052
    [No Abstract]   [Full Text] [Related]  

  • 35. Cross-protection in Neisseria meningitidis serogroups Y and W polysaccharides: A comparative conformational analysis.
    Kuttel MM; Timol Z; Ravenscroft N
    Carbohydr Res; 2017 Jun; 446-447():40-47. PubMed ID: 28501716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes.
    Craven DE; Shen KT; Frasch CE
    Infect Immun; 1982 Jul; 37(1):132-7. PubMed ID: 6809622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection of an immunogenic peptide mimic of the capsular polysaccharide of Neisseria meningitidis serogroup A using a peptide display library.
    Grothaus MC; Srivastava N; Smithson SL; Kieber-Emmons T; Williams DB; Carlone GM; Westerink MA
    Vaccine; 2000 Jan; 18(13):1253-63. PubMed ID: 10649627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.
    Granoff DM; Bartoloni A; Ricci S; Gallo E; Rosa D; Ravenscroft N; Guarnieri V; Seid RC; Shan A; Usinger WR; Tan S; McHugh YE; Moe GR
    J Immunol; 1998 May; 160(10):5028-36. PubMed ID: 9590252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Evaluation of a Multiplex Microsphere Assay for Quantitation of IgG and IgA Antibodies against Neisseria meningitidis Serogroup A, C, W, and Y Polysaccharides.
    Bårnes GK; Kristiansen PA; Caugant DA; Næss LM
    Clin Vaccine Immunol; 2015 Jul; 22(7):697-705. PubMed ID: 25924767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the ontogeny of the murine humoral response to Neisseria meningitidis B capsular polysaccharide reveals levels of complexity relevant to vaccine development.
    Colino J; Outschoorn I
    J Infect Dis; 2001 Dec; 184(12):1538-47. PubMed ID: 11740729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.